T829-1773 Screening compound: 1-{5-[(3-fluorophenyl)methyl]-2-methyl-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}-4-methyl-1,4-diazepane

T829-1773 Screening compound: 1-{5-[(3-fluorophenyl)methyl]-2-methyl-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}-4-methyl-1,4-diazepane
T829-1773 Screening compound: 1-{5-[(3-fluorophenyl)methyl]-2-methyl-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}-4-methyl-1,4-diazepane alternative view

Chemical Structure Depiction of ChemDiv screening compound T829-1773
1-{5-[(3-fluorophenyl)methyl]-2-methyl-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}-4-methyl-1,4-diazepane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T829-1773

Molecular Formula

C22H28FN3O2 (C22 H28 FN3 O2)

Compound Name

1-{5-[(3-fluorophenyl)methyl]-2-methyl-4H,5H,6H,7H-furo[3,2-c]pyridine-3-carbonyl}-4-methyl-1,4-diazepane

IUPAC name

1-{5-[(3-fluorophenyl)methyl]-2-methyl-4H5H6H7H-furo[32-c]pyridine-3-carbonyl}-4-methyl-14-diazepane

SMILES

Cc1c(C(N2CCN(C)CCC2)=O)c(CN(Cc2cccc(F)c2)CC2)c2o1

InChI

InChI=1S/C22H28FN3O2/c1-16-21(22(27)26-9-4-8-24(2)11-12-26)19-15-25(10-7-20(19)28-16)14-17-5-3-6-18(23)13-17/h3,5-6,13H,4,7-12,14-15H2,1-2H3

InChI Key

KAUXLWYWJWUKRY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28995071

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

385.48

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.246

Distribution Coefficient, logD

-2.228

Water Solubility, LogSw

-2.57

Polar Surface Area

32.316

Acid Dissociation Constant (pKa)

25.85

Base Dissociation Constant (pKb)

11.87

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

T829-1773 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS BBB Library (22607 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Hemic and lymphatic
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with T829-1773 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T829-1773?
Check Price and Availability of T829-1773, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T829-1773 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T829-1773
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T829-1773
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T829-1773 available by request